about
Different anthracycline derivates for reducing cardiotoxicity in cancer patientsCardioprotective interventions for cancer patients receiving anthracyclinesDifferent anthracycline derivates for reducing cardiotoxicity in cancer patientsDifferent dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyCardioprotective interventions for cancer patients receiving anthracyclinesDifferent dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyA cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets WolbachiaQuantitative proteomic analysis reveals the perturbation of multiple cellular pathways in jurkat-T cells induced by doxorubicinAKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent.Trastuzumab-induced cardiac dysfunction: A 'dual-hit'Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice.Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study.The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.Antineoplastic drugs and their analysis: a state of the art review.Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress.Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.An in silico approach to map the binding site of doxorubicin on hemoglobin.Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study.Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease.
P2860
Q24235507-FCD4399E-13A8-465A-B2BD-29AB1227B25CQ24236338-DF6C8A1C-B3B7-4E06-8011-FDF5DC4B3E66Q24236622-58072840-54E4-4D58-93EE-7FA416C971EBQ24240568-8D2AB7A3-EAF3-4DBB-A46E-9C5553662FB6Q24243021-500ADA5B-B22B-4D6B-BF04-8D8E4DF5B45CQ24243810-499543BC-FD08-413D-9DBA-3A5D6A169EDEQ27342384-338332B0-0CBC-47E1-BB2C-E54D11952735Q34283227-5954C93B-3EB9-492A-B927-4C77D4935FB5Q35141326-AC29EEA7-DB08-4366-A858-44F9B9F438C6Q35163699-08BE8740-8206-4DE9-BA38-AF2CE2850A16Q35532125-99753E6D-1097-4BA5-A5D3-A908FCD55E4FQ36115043-8581057C-E702-4C1A-96A2-16E30B17018CQ36141213-222D10EC-B392-445D-A69A-E4D003B5A623Q37020999-2243DD44-058D-435A-BAF7-D22F11E99EF0Q38383524-63AE0581-2EBD-4BB5-9E3A-0BAE7277CE56Q39339684-39E4281A-C3CF-4968-BBC0-98A340ACD428Q39421561-F161BF4C-CC07-4937-8D96-EC6C292BDC73Q41282935-E86A5F6C-3C4E-4548-B3C9-9DC56811F37FQ41337826-238B897C-4647-4E8A-88B4-774741D49002Q42434532-0C583C6D-1147-4E88-83B9-6D3BB439FF5FQ43973231-DECC0CEA-389F-4109-BD22-5526ABF87539Q48771662-694C05F2-3755-421F-8C2F-4EE7686761E7
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականին հրատարակուած գիտական յօդուած
@hyw
1991 թվականին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
New anthracycline antitumor antibiotics
@ast
New anthracycline antitumor antibiotics
@en
New anthracycline antitumor antibiotics
@nl
type
label
New anthracycline antitumor antibiotics
@ast
New anthracycline antitumor antibiotics
@en
New anthracycline antitumor antibiotics
@nl
prefLabel
New anthracycline antitumor antibiotics
@ast
New anthracycline antitumor antibiotics
@en
New anthracycline antitumor antibiotics
@nl
P3181
P1476
New anthracycline antitumor antibiotics
@en
P2093
P3181
P356
10.1016/1040-8428(91)90017-7
P407
P577
1991-01-01T00:00:00Z